Markets:

Overview

News

Currencies

International

Treasuries

Johnson & Johnson (NY:JNJ)

230.80 +0.38 (+0.16%)

Official Closing Price Updated: 7:00 PM EDT, May 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

99 100 Next >

Wall Street Suffers Worst Day Since April as Trump Revives Trade War Fears ↗

October 13, 2025

U.S. markets were rattled on Friday after President Trump reignited trade tensions with China, triggering the sharpest sell-off since April. Tech and AI stocks led the decline, while gold and...

Via Chartmill

Douglas Lane Adds $6 Million in J&J Stock Ahead of Earnings and Possible Biotech Deal ↗

October 12, 2025

Via The Motley Fool

Topics Regulatory Compliance

US Government Shutdown Rattles Global Markets, Igniting Uncertainty and Fueling Losses on October 10, 2025

October 10, 2025

The ongoing U.S. federal government shutdown, now in its tenth day as of October 10, 2025, has sent significant tremors through global financial markets. The persistent congressional deadlock over...

Via MarketMinute

Topics Bonds Economy World Trade

Why Did Protagonist Therapeutics Stock Soar Today? ↗

October 10, 2025

Via Stocktwits

Johnson & Johnson recommends shareholders reject “mini-tender” offer by Tutanota

October 10, 2025

From Johnson & Johnson

Via Business Wire

Market Turmoil: S&P 500 and Nasdaq Plunge Amidst Renewed Trade Tensions and AI Scrutiny

October 10, 2025

New York, NY – October 10, 2025 – U.S. equity markets experienced a dramatic downturn today, with both the S&P 500 and Nasdaq Composite indices recording substantial losses, shattering a months-long...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Johnson & Johnson In Talks To Acquire Protagonist Therapeutics: Report ↗

October 10, 2025

Johnson & Johnson is in talks to buy Protagonist Therapeutics in a deal that could expand its immunology and cancer drug portfolio.

Via Benzinga

Is This Beaten-Down Dividend King a Buy? ↗

October 10, 2025

This company's short life on the stock market has been a constant challenge.

Via The Motley Fool

Topics Intellectual Property

Johnson & Johnson Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗

October 10, 2025

Via Benzinga

Pfizer (NYSE:PFE) Marks 348th Consecutive Dividend Payment: A Pillar of Stability Amidst Transformation

October 09, 2025

New York, NY – October 9, 2025 – Pfizer Inc. (NYSE:PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Government Shutdown Casts a Shadow: Economic Data Halted, Federal Reserve Navigates Blind

October 09, 2025

The ongoing government shutdown has plunged financial markets into a state of heightened uncertainty, as the vital flow of economic data—the lifeblood of informed decision-making—grinds to a halt. With...

Via MarketMinute

Topics Bonds Credit Cards Economy

Pfizer's 348th Consecutive Dividend: A Beacon of Stability Amidst Industry Headwinds

October 09, 2025

New York, NY – October 9, 2025 – Pfizer Inc. (NYSE: PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of...

Via MarketMinute

Topics Economy Intellectual Property Retirement

Dow Jones Takes a Tumble Amidst Government Shutdown Fears and Economic Headwinds

October 09, 2025

The Dow Jones Industrial Average (DJIA) experienced a notable slide today, October 9, 2025, as a confluence of a U.S. government shutdown, mounting economic concerns, and specific corporate...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Johnson & Johnson to Participate in the UBS Global Healthcare Conference

October 09, 2025

From Johnson & Johnson

Via Business Wire

What Analysts Are Saying About Johnson & Johnson Stock ↗

October 09, 2025

Via Benzinga

Top US Bankers Sound Alarm: Brace for Potential Stock Market Decline

October 09, 2025

In a series of recent and increasingly pointed warnings, some of America's most influential financial leaders are cautioning investors to prepare for a significant stock market downturn within the...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Investors Brace for Pullback as Short-Bias ETF Inflows Signal Growing Bearishness

October 09, 2025

A significant surge in capital flowing into short-bias Exchange-Traded Funds (ETFs) has sent a clear signal through the financial markets: investor sentiment is shifting towards caution and a potential...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

Market Giants Retreat: S&P 500 and Nasdaq Pull Back from Record Highs Amidst Economic Headwinds

October 09, 2025

The relentless ascent of the U.S. stock market has hit a significant speed bump, as both the S&P 500 and Nasdaq Composite have retreated from their recent record highs. This pullback, occurring after...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

The Looming Spectre: What Could Puncture the Stock Market's AI-Driven Bubble?

October 09, 2025

As October 2025 unfolds, a palpable tension hangs over global financial markets. Despite record highs in major indices like the Nasdaq 100 (NASDAQ: NDX) and the FTSE 100 (LSE: UKX), a growing chorus of...

Via MarketMinute

Topics Artificial Intelligence Economy Supply Chain

Federal Reserve Navigates Rate Cuts Amidst Lingering Inflationary Shadows

October 08, 2025

The Federal Reserve has embarked on a delicate balancing act, initiating interest rate cuts in 2025 to bolster a softening labor market while grappling with persistent inflation concerns among some of...

Via MarketMinute

Topics Derivatives Economy Stocks

FDA Expands Johnson & Johnson Ulcerative Colitis Drug Approval To Pediatric Patients ↗

October 08, 2025

FDA approves Johnson & Johnson's Simponi for children with moderate to severe ulcerative colitis, supported by positive Phase 3 trial results.

Via Benzinga

These Were the 5 Worst-Performing Stocks in the S&P 500 in September 2025 -- and One's Decline Can Be Tied to President Trump ↗

October 08, 2025

One of these stocks lost about a quarter of its value in a single month.

Via The Motley Fool

Topics Government Stocks World Trade

Why AbbVie and Johnson & Johnson Could Outperform Pfizer ↗

October 08, 2025

Pfizer stock is moving higher after being named part of the TrumpRx platform; but two other biopharma companies may offer better long-term growth potential

Via MarketBeat

Worried About a Recession? 2 Stocks to Buy Now to Prepare Your Portfolio ↗

October 07, 2025

These two market leaders have increased their dividends for a combined 115 years.

Via The Motley Fool

Topics Economy Government Supply Chain

Congresswoman Violates STOCK Act With Late Trade Disclosures: Purchases Include Bitcoin ETF ↗

October 07, 2025

As legislation in Congress heats up to ban elected officials from buying and selling stocks, several members have violated the STOCK Act in 2025, failing to disclose their transactions in a timely...

Via Benzinga

Healthcare Sector Defies Broader Market Swings, Leads S&P 500 Momentum on October 7, 2025

October 07, 2025

On a day where the broader S&P 500 and Nasdaq Composite indices soared to new all-time record highs, the S&P 500 Healthcare sector presented a compelling, albeit nuanced, narrative of market leadership...

Via MarketMinute

Topics Artificial Intelligence ETFs Intellectual Property

Johnson & Johnson Reportedly Ordered To Pay $966M To Family Of Woman Who Died Of Rare Cancer Allegedly Associated With Its Talc ↗

October 07, 2025

According to a Reuters report, a Los Angeles Jury has ordered the company to pay $16 million in compensatory damages and $950 million in punitive damages.

Via Stocktwits

Topics Bankruptcy Death Lawsuit

Top S&P500 movers in Tuesday's pre-market session ↗

October 07, 2025

The US market session of Tuesday has yet to be opened, let's have a look at the top S&P500 gainers and losers in the pre-market session today.

Via Chartmill

1 Reason I'm Watching Intuitive Surgical Stock in 2026 ↗

October 07, 2025

The surgical robotics pioneer could cement its leading position for years to come.

Via The Motley Fool

U.S. Labor Market Stalls: Moody's Reports 'Essentially No Job Growth' Amidst Government Shutdown, Raising Recession Fears

October 06, 2025

Washington D.C., October 6, 2025 – The American labor market appears to have hit a significant speed bump, with Moody's Analytics reporting "essentially no job growth" for the U.S. in September 2025....

Via MarketMinute

Topics Artificial Intelligence Credit Cards Economy

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.